Germline mutations in 6 genes associated with pancreatic cancer (ATM, BRCA1, BRCA2, CDKN2A, MLH1, and TP53) were found in 5.5% of all patients with pancreatic cancer (11). This evidence concerns the gene TP53 and pancreatic neoplasm.